financetom
Business
financetom
/
Business
/
US Regulator, Spirit AeroSystems Probe 'Counterfeit' Titanium Possibly Used in Boeing, Airbus Planes
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US Regulator, Spirit AeroSystems Probe 'Counterfeit' Titanium Possibly Used in Boeing, Airbus Planes
Jun 14, 2024 8:41 AM

11:15 AM EDT, 06/14/2024 (MT Newswires) -- The US Federal Aviation Administration and Spirit AeroSystems ( SPR ) are investigating fake documents certifying the authenticity of titanium that may have been used in some Boeing ( BA ) and Airbus airplanes.

"This is about titanium that has entered the supply system via documents that have been counterfeited," a Spirit spokesperson said Friday in an emailed statement to MT Newswires.

"When this was identified, all suspect parts were quarantined and removed from Spirit production," the Spirit spokesperson said. "More than 1,000 tests have been completed to confirm the mechanical and metallurgical properties of the affected material to ensure continued airworthiness."

A Federal Aviation Administration spokesperson said Boeing ( BA ) reported a "voluntary disclosure to the FAA regarding procurement of material through a distributor who may have falsified or provided incorrect records."

"Boeing ( BA ) issued a bulletin outlining ways suppliers should remain alert to the potential of falsified records," the FAA spokesperson said in an emailed statement. "The FAA is investigating the scope and impact of the issue through our continued operational safety process."

A Boeing ( BA ) spokesperson said in an emailed statement, "This industry-wide issue affects some shipments of titanium received by a limited set of suppliers, and tests performed to date have indicated that the correct titanium alloy was used."

"To ensure compliance, we are removing any affected parts on airplanes prior to delivery," the Boeing ( BA ) spokesperson said. "Our analysis shows the in-service fleet can continue to fly safely."

Boeing ( BA ) shares fell 1.8% in recent trading Friday.

Price: 177.40, Change: -3.30, Percent Change: -1.83

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Market Chatter: Lockheed Delivers 72 F-35 Jets After Software Delays, Payments Still Withheld
Market Chatter: Lockheed Delivers 72 F-35 Jets After Software Delays, Payments Still Withheld
Jul 15, 2025
07:30 AM EDT, 07/15/2025 (MT Newswires) -- Lockheed Martin ( LMT ) delivered all 72 F-35 jets that had been parked at its Fort Worth, Texas, facility as of May 1 due to delayed software upgrades, Bloomberg News reported Tuesday, citing the Pentagon's program office. The Defense Department had reportedly been withholding up to $5 million per jet until the...
Aquestive Therapeutics Says Canadian Regulator Has Granted Meeting to Discuss Anaphylm Approval
Aquestive Therapeutics Says Canadian Regulator Has Granted Meeting to Discuss Anaphylm Approval
Jul 15, 2025
07:31 AM EDT, 07/15/2025 (MT Newswires) -- Aquestive Therapeutics ( AQST ) said Tuesday that Health Canada has granted a meeting with the company in Q3 to discuss the latter's planned new drug submission for Anaphylm sublingual film, an orally injected emergency treatment for serious allergic reactions, including anaphylaxis. The company said it has also submitted an initial briefing book...
Kailera touts late-stage win for weight-loss drug in China
Kailera touts late-stage win for weight-loss drug in China
Jul 15, 2025
By Mariam Sunny July 15 (Reuters) - U.S.-based Kailera Therapeutics and Chinese firm Jiangsu Hengrui Pharmaceuticals' experimental weight-loss drug has helped overweight patients lose up to 17.7% of body weight in a late-stage study in China, the companies said on Tuesday. Up to 88% of participants who received the drug, known as KAI-9531 outside China, lost at least 5% of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved